<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:25:58Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9041071" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9041071</identifier>
        <datestamp>2022-04-28</datestamp>
        <setSpec>canmed</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="cam44565" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Cancer Med</journal-id>
              <journal-id journal-id-type="iso-abbrev">Cancer Med</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2045-7634</journal-id>
              <journal-id journal-id-type="publisher-id">CAM4</journal-id>
              <journal-title-group>
                <journal-title>Cancer Medicine</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2045-7634</issn>
              <publisher>
                <publisher-name>Blackwell Publishing Ltd</publisher-name>
                <publisher-loc>Oxford, UK</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9041071</article-id>
              <article-id pub-id-type="pmcid">PMC9041071</article-id>
              <article-id pub-id-type="pmc-uid">9041071</article-id>
              <article-id pub-id-type="pmid">35142091</article-id>
              <article-id pub-id-type="pmid">35142091</article-id>
              <article-id pub-id-type="doi">10.1002/cam4.4565</article-id>
              <article-id pub-id-type="publisher-id">CAM44565</article-id>
              <article-id pub-id-type="other">CAM4-2021-07-3016.R1</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Cancer Prevention</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Research Articles</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Impact of early palliative care according to baseline symptom severity: Secondary analysis of a cluster‚Äêrandomized controlled trial in patients with advanced cancer</article-title>
                <alt-title alt-title-type="left-running-head">Rodin et al.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="cam44565-cr-0001" contrib-type="author">
                  <name>
                    <surname>Rodin</surname>
                    <given-names>Rebecca</given-names>
                  </name>
                  <degrees>MD, MSc</degrees>
                  <xref rid="cam44565-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cam44565-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="cam44565-cr-0002" contrib-type="author">
                  <name>
                    <surname>Swami</surname>
                    <given-names>Nadia</given-names>
                  </name>
                  <degrees>BSc</degrees>
                  <xref rid="cam44565-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="cam44565-cr-0003" contrib-type="author">
                  <name>
                    <surname>Pope</surname>
                    <given-names>Ashley</given-names>
                  </name>
                  <degrees>BSc</degrees>
                  <xref rid="cam44565-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="cam44565-cr-0004" contrib-type="author">
                  <name>
                    <surname>Hui</surname>
                    <given-names>David</given-names>
                  </name>
                  <degrees>MD, MSc</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2733-6607</contrib-id>
                  <xref rid="cam44565-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="cam44565-cr-0005" contrib-type="author">
                  <name>
                    <surname>Hannon</surname>
                    <given-names>Breffni</given-names>
                  </name>
                  <degrees>MD, MSc</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0881-555X</contrib-id>
                  <xref rid="cam44565-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cam44565-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="cam44565-cr-0006" contrib-type="author">
                  <name>
                    <surname>Le</surname>
                    <given-names>Lisa W.</given-names>
                  </name>
                  <degrees>MSc</degrees>
                  <xref rid="cam44565-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="cam44565-cr-0007" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Zimmermann</surname>
                    <given-names>Camilla</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4889-0244</contrib-id>
                  <xref rid="cam44565-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cam44565-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="cam44565-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                  <xref rid="cam44565-aff-0006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                  <address>
                    <email>camilla.zimmermann@uhn.ca</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="cam44565-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Department of Medicine</named-content>
                <institution>University of Toronto</institution>
                <city>Toronto</city>
                <named-content content-type="country-part">Ontario</named-content>
                <country country="CA">Canada</country>
              </aff>
              <aff id="cam44565-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Department of Supportive Care, Princess Margaret Cancer Centre</named-content>
                <institution>University Health Network</institution>
                <city>Toronto</city>
                <named-content content-type="country-part">Ontario</named-content>
                <country country="CA">Canada</country>
              </aff>
              <aff id="cam44565-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Department of Palliative Care, Rehabilitation, and Integrative Medicine, and Department of General Oncology</named-content>
                <institution>The University of Texas MD Anderson Cancer Center</institution>
                <city>Houston</city>
                <named-content content-type="country-part">Texas</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cam44565-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Department of Biostatistics, Princess Margaret Cancer Centre</named-content>
                <institution>University Health Network</institution>
                <city>Toronto</city>
                <named-content content-type="country-part">Ontario</named-content>
                <country country="CA">Canada</country>
              </aff>
              <aff id="cam44565-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Department of Psychiatry</named-content>
                <institution>University of Toronto</institution>
                <city>Toronto</city>
                <named-content content-type="country-part">Ontario</named-content>
                <country country="CA">Canada</country>
              </aff>
              <aff id="cam44565-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <named-content content-type="organisation-division">Princess Margaret Research Institute, Princess Margaret Cancer Centre</named-content>
                <institution>University Health Network</institution>
                <city>Toronto</city>
                <named-content content-type="country-part">Ontario</named-content>
                <country country="CA">Canada</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Dr. Camilla Zimmermann, Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, 620 University Ave., room 12‚Äê300, Toronto, ON, M5G 2C1, Canada.<break/>
Email: <email>camilla.zimmermann@uhn.ca</email>
<break/>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>09</day>
                <month>2</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>4</month>
                <year>2022</year>
              </pub-date>
              <volume>11</volume>
              <issue seq="150">8</issue>
              <issue-id pub-id-type="doi">10.1002/cam4.v11.8</issue-id>
              <fpage>1869</fpage>
              <lpage>1878</lpage>
              <history>
                <date date-type="rev-recd">
                  <day>19</day>
                  <month>11</month>
                  <year>2021</year>
                </date>
                <date date-type="received">
                  <day>19</day>
                  <month>7</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>21</day>
                  <month>11</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <!--&#x000a9; 2022 Published by John Wiley & Sons Ltd.-->
                <copyright-statement content-type="article-copyright">¬© 2022 The Authors. <italic toggle="yes">Cancer Medicine</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:CAM4-11-1869.pdf"/>
              <abstract>
                <title>Abstract</title>
                <sec id="cam44565-sec-0001">
                  <title>Background</title>
                  <p>Early palliative care (EPC) improves the quality of life but may not be feasible for all patients with advanced cancer. Symptom screening has been suggested to triage patients for EPC, but scant evidence exists for this practice.</p>
                </sec>
                <sec id="cam44565-sec-0002">
                  <title>Methods</title>
                  <p>We conducted a subgroup analysis of a cluster‚Äêrandomized controlled trial of EPC vs. standard oncology care according to patients' baseline symptom scores (high [&gt;23] vs. low [‚â§23] Edmonton Symptom Assessment System Distress Score [ESAS SDS]). A linear mixed‚Äêeffects model was used to account for correlation within clusters, adjusting for the baseline outcome score and all covariates in the original trial.</p>
                </sec>
                <sec id="cam44565-sec-0003">
                  <title>Results</title>
                  <p>Among the 461 participants, baseline symptom scores were high in 229 patients (127 intervention, 102 control) and low in 232 (101 intervention and 131 control). Among those with high baseline symptoms, there was improved quality of life in the EPC arm compared to controls at 4¬†months (adjusted difference in primary outcome of FACIT‚ÄêSp change score [95% CI], 8.7 [2.8 to 14.5], <italic toggle="no">p</italic>¬†=¬†0.01; adjusted difference in QUAL‚ÄêE, 4.2 [0.9‚Äì7.5], <italic toggle="no">p</italic>¬†=¬†0.02); there was also improved satisfaction with care (6.9 [3.8‚Äì9.9], <italic toggle="no">p</italic>¬†=¬†0.001) and clinician‚Äêpatient interactions (‚àí1.7 [‚àí3.4 to ‚àí0.1], <italic toggle="no">p</italic>¬†=¬†0.04), but no significant difference in ESAS SDS (‚àí5.6 [‚àí12.7 to 1.4], <italic toggle="no">p</italic>¬†=¬†0.11). In the low baseline symptom group, there were no significant differences between arms for any outcomes.</p>
                </sec>
                <sec id="cam44565-sec-0004">
                  <title>Conclusion</title>
                  <p>EPC improved quality of life, satisfaction with care, and clinician‚Äêpatient interactions only in those with high baseline symptoms. Symptom severity may be an appropriate criterion to trigger early referrals to palliative care.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="cam44565-kwd-0001">cancer</kwd>
                <kwd id="cam44565-kwd-0002">palliative care</kwd>
                <kwd id="cam44565-kwd-0003">quality of life</kwd>
                <kwd id="cam44565-kwd-0004">randomized controlled trial</kwd>
                <kwd id="cam44565-kwd-0005">secondary analysis</kwd>
                <kwd id="cam44565-kwd-0006">symptom assessment</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>Canadian Cancer Society Research Institute
</institution>
                      <institution-id institution-id-type="doi">10.13039/501100000015</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>700862</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>Canadian Institutes of Health Research
</institution>
                      <institution-id institution-id-type="doi">10.13039/501100000024</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>152996</award-id>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>
                    <institution-wrap>
                      <institution>Princess Margaret Cancer Foundation
</institution>
                      <institution-id institution-id-type="doi">10.13039/100009812</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>
                    <institution-wrap>
                      <institution>Princess Margaret Cancer Centre/University Health Network
</institution>
                      <institution-id institution-id-type="doi">10.13039/100009663</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0005">
                  <funding-source>
                    <institution-wrap>
                      <institution>University of Toronto
</institution>
                      <institution-id institution-id-type="doi">10.13039/501100003579</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="3"/>
                <page-count count="10"/>
                <word-count count="5691"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>April 2022</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.4 mode:remove_FC converted:26.04.2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="CAM44565-cit-2001"><string-name><surname>Rodin</surname><given-names>R</given-names></string-name>, <string-name><surname>Swami</surname><given-names>N</given-names></string-name>, <string-name><surname>Pope</surname><given-names>A</given-names></string-name>, <string-name><surname>Hui</surname><given-names>D</given-names></string-name>, <string-name><surname>Hannon</surname><given-names>B</given-names></string-name>, <string-name><surname>Le</surname><given-names>LW</given-names></string-name>, <string-name><surname>Zimmermann</surname><given-names>C</given-names></string-name>. <article-title>Impact of early palliative care according to baseline symptom severity: Secondary analysis of a cluster‚Äêrandomized controlled trial in patients with advanced cancer</article-title>. <source>Cancer Med</source>. <year>2022</year>;<volume>11</volume>:<fpage>1869</fpage>‚Äì<lpage>1878</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cam4.4565</pub-id>
</mixed-citation>
              </p>
            </notes>
          </front>
          <body id="cam44565-body-0001">
            <sec id="cam44565-sec-0005">
              <label>1</label>
              <title>INTRODUCTION</title>
              <p>Patients with advanced cancer suffer from multiple physical and psychosocial symptoms.<xref rid="cam44565-bib-0001" ref-type="bibr"><sup>1</sup></xref>, <xref rid="cam44565-bib-0002" ref-type="bibr"><sup>2</sup></xref> Randomized controlled trials have demonstrated that integration of specialized palliative care within oncology early in the course of disease improves quality of life and symptom burden.<xref rid="cam44565-bib-0003" ref-type="bibr"><sup>3</sup></xref>, <xref rid="cam44565-bib-0004" ref-type="bibr"><sup>4</sup></xref>, <xref rid="cam44565-bib-0005" ref-type="bibr"><sup>5</sup></xref>, <xref rid="cam44565-bib-0006" ref-type="bibr"><sup>6</sup></xref> However, universal implementation of early specialized palliative care is not feasible, given the shortage of specialized palliative care clinicians.<xref rid="cam44565-bib-0007" ref-type="bibr"><sup>7</sup></xref>, <xref rid="cam44565-bib-0008" ref-type="bibr"><sup>8</sup></xref> A more realistic model may be one in which basic palliative care needs are provided by oncologists, while complex problems are addressed by palliative care specialists.<xref rid="cam44565-bib-0009" ref-type="bibr"><sup>9</sup></xref>
</p>
              <p>Routine symptom screening is increasingly being implemented at cancer centers and may provide a means of identifying patients who would benefit from specialized palliative care.<xref rid="cam44565-bib-0010" ref-type="bibr"><sup>10</sup></xref>, <xref rid="cam44565-bib-0011" ref-type="bibr"><sup>11</sup></xref>, <xref rid="cam44565-bib-0012" ref-type="bibr"><sup>12</sup></xref> Risk‚Äêstratifying patients according to symptoms may lead to a more equitable distribution of specialized palliative care resources to those with the greatest need and with the greatest potential for benefit. Further, automatic triggering of palliative care referrals based on such criteria could help to diminish stigma and increase the acceptance of palliative care by both patients and providers.<xref rid="cam44565-bib-0013" ref-type="bibr"><sup>13</sup></xref>, <xref rid="cam44565-bib-0014" ref-type="bibr"><sup>14</sup></xref>
</p>
              <p>We previously reported on the results of a cluster‚Äêrandomized controlled trial that examined the impact of early palliative care provided in a specialized palliative care clinic on multiple patient‚Äêreported outcomes.<xref rid="cam44565-bib-0003" ref-type="bibr"><sup>3</sup></xref> Compared to those receiving standard oncology care, patients assigned to the early palliative care group had improved quality of life, symptom control, and satisfaction with care 4¬†months after randomization. There was no difference between the intervention and standard care arms in difficulties with clinician‚Äêpatient interactions.</p>
              <p>The aim of the current analysis was to examine whether outcomes of this cluster‚Äêrandomized trial differed between subgroups according to symptom severity at baseline. We hypothesized that early palliative care would be associated with greater improvements in quality of life, symptom control, satisfaction with care, and clinician‚Äìpatient interactions in those with high symptom burden at baseline, compared to those with low symptom burden at baseline.</p>
            </sec>
            <sec sec-type="methods" id="cam44565-sec-0006">
              <label>2</label>
              <title>METHODS</title>
              <sec id="cam44565-sec-0007">
                <label>2.1</label>
                <title>Study design and participants</title>
                <p>We conducted a cluster‚Äêrandomized controlled trial comparing specialized early palliative care to standard oncology care in patients with advanced cancer. The trial was conducted between December 1, 2006, and February 28, 2011, at the Princess Margaret Cancer Centre, a comprehensive cancer center in Toronto, Canada. Patients provided written informed consent to participate and the study was approved by the Research Ethics Board of the University Health Network.</p>
                <p>Twenty‚Äêfour medical oncology clinics from breast, gastrointestinal, genitourinary, lung, or gynecological tumor sites were cluster‚Äêrandomized according to tumor site and clinic size in a 1:1 ratio using a computer‚Äêgenerated sequence by a statistical team at Western University. Patients were approached for consent to participate in one of the two study arms (unaware of the other group), depending on the randomization of the clinic. Blinding of medical oncologists or study investigators was not possible.</p>
                <p>Patients eligible to participate in the trial were at least 18¬†years old, had stage IV cancer (or breast or prostate cancer refractory to hormonal therapy); an estimated survival of 6‚Äì24¬†months, as determined by their primary oncologist; and an Eastern Cooperative Oncology Group (ECOG) performance score of 0, 1, or 2. Participants were recruited from 24 oncology clinics. Those with insufficient English literacy or cognitive impairment (Short Orientation‚ÄêMemory‚ÄêConcentration Test score &lt;20 or &gt;10 errors) were excluded from the study. The early palliative care intervention has been described in detail elsewhere.<xref rid="cam44565-bib-0003" ref-type="bibr"><sup>3</sup></xref>, <xref rid="cam44565-bib-0015" ref-type="bibr"><sup>15</sup></xref> It consisted of the following main components: (1) a comprehensive, 60‚Äì90¬†min, multidisciplinary, in‚Äêperson assessment within 1 month of recruitment, focusing on symptoms, psychological distress, social support, and home services; (2) routine telephone contact from a palliative care nurse 1 week after the first consultation, and thereafter as needed; (3) monthly outpatient palliative care follow‚Äêup (20‚Äì50¬†min); and (4) a 24‚Äêh on‚Äêcall service for telephone management of urgent issues. Additional interventions were provided depending on the status of the patient, including arrangement of home nursing or palliative physician care or transfer to the Princess Margaret Cancer Centre palliative care inpatient unit.</p>
                <p>Data on demographic factors, treatment status, Charlson Comorbidity Index (CCI), and ECOG performance status were collected at baseline. Participants completed measures at baseline and 4¬†months after randomization to assess the quality of life, symptom severity, satisfaction with care, and clinician‚Äêpatient interactions.</p>
                <p>Quality of life was assessed using two measures that evaluated different domains. The Functional Assessment of Chronic Illness Therapy‚ÄîSpiritual Well‚ÄêBeing (FACIT‚ÄêSp) includes physical, social and family, emotional, functional, and spiritual domains of quality of life, with scores ranging from 0 to 156 (higher scores representing better quality of life).<xref rid="cam44565-bib-0016" ref-type="bibr"><sup>16</sup></xref>, <xref rid="cam44565-bib-0017" ref-type="bibr"><sup>17</sup></xref> The Quality of Life at the End of Life (QUAL‚ÄêE) evaluates domains of life completion, symptoms, relationship with healthcare provider, and preparation for the end of life. The total scores range from 21 to 105, with higher scores indicating better quality of life.<xref rid="cam44565-bib-0018" ref-type="bibr"><sup>18</sup></xref>
</p>
                <p>The Edmonton Symptom Assessment System (ESAS) is a measure of symptom burden that includes a Likert rating of nine symptoms (pain, fatigue, drowsiness, nausea, anxiety, depression, appetite, dyspnea, and wellbeing) on a scale from 0 (best) to 10 (worst).<xref rid="cam44565-bib-0019" ref-type="bibr"><sup>19</sup></xref> The nine individual symptom scores are summed to yield the ESAS Symptom Distress Score (ESAS SDS), ranging from 0 to 90, with higher scores indicating worse symptom burden.<xref rid="cam44565-bib-0020" ref-type="bibr"><sup>20</sup></xref> The FAMCARE‚ÄêP16 patient satisfaction with care measure assesses satisfaction with care, including information‚Äêgiving, availability of care, psychological care, and physical care in patients with advanced cancer, with scores ranging from 16 to 80; higher scores indicate greater satisfaction with care.<xref rid="cam44565-bib-0021" ref-type="bibr"><sup>21</sup></xref>, <xref rid="cam44565-bib-0022" ref-type="bibr"><sup>22</sup></xref> The Cancer Rehabilitation Evaluation System Medical Interaction Subscale (CARES‚ÄêMIS) evaluates specific problems of patients in their interactions with nurses and doctors, including those related to information seeking and communication with the medical team (range 0‚Äì44); higher scores indicate greater difficulties with interactions.<xref rid="cam44565-bib-0023" ref-type="bibr"><sup>23</sup></xref>
</p>
                <p>The primary outcome for the present analysis was change in patient‚Äêreported FACIT‚ÄêSp scores at 4¬†months. Secondary outcomes were change in patient‚Äêreported QUAL‚ÄêE, ESAS SDS, FAMCARE‚ÄêP16, and CARES‚ÄêMIS scores at 4¬†months compared to baseline. We hypothesized that patients with greater symptom burden at baseline would have greater improvement in quality of life and other outcomes after receiving the early palliative care intervention compared to those with low baseline symptom burden.</p>
              </sec>
              <sec id="cam44565-sec-0008">
                <label>2.2</label>
                <title>Data analysis</title>
                <p>Sample size justification for the original trial was reported previously.<xref rid="cam44565-bib-0003" ref-type="bibr"><sup>3</sup></xref> We grouped patients according to their baseline ESAS SDS scores, relative to the median: the high baseline symptom group was defined by those with baseline ESAS SDS scores above the median and the low baseline symptom group by those with baseline ESAS SDS scores at or below the median. A median split was used to determine these subgroups in order to maximize power for the subgroup analyses. The primary outcome of FACIT‚ÄêSp, as well as the secondary outcomes of QUALE‚ÄêE, ESAS SDS, FAMCARE‚ÄêP16, and CARES‚ÄêMIS, was assessed within the high and low symptom subgroups based on the change in score at 4¬†months from baseline.</p>
                <p>A linear mixed‚Äêeffects model was used for all analyses to account for the correlation within clusters, adjusting for the corresponding baseline quality of life score and all baseline covariates in the original randomized trial, including age, tumor site, baseline ECOG score, and receiving chemotherapy.<xref rid="cam44565-bib-0003" ref-type="bibr"><sup>3</sup></xref> Interaction between study arm and baseline symptom group was examined for each outcome by using the appropriate product term in the mixed‚Äêeffect model. In addition, the mean observed change from baseline was compared between intervention and standard care groups within each baseline symptom subgroup; adjusted differences in change scores between study arms and their associated 95% confidence intervals (CI) were reported for each baseline symptom group. Similar to the analysis for the original trial, all analyses were by intention to treat, and sensitivity analyses were performed using Markov Chain Monte Carlo (MCMC) multiple imputation for missing values.<xref rid="cam44565-bib-0003" ref-type="bibr"><sup>3</sup></xref> All analyses were performed using SAS statistical software (version 9.4) and two‚Äêsided <italic toggle="yes">p</italic>‚Äêvalues below 0.05 were considered significant.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="cam44565-sec-0009">
              <label>3</label>
              <title>RESULTS</title>
              <p>The median age of all trial participants (<italic toggle="yes">n</italic>¬†=¬†461; 228 intervention, 233 control) was 61¬†years and the median baseline ESAS SDS score was 23 (range 2‚Äì78, interquartile range 13‚Äì36). Of the 461 participants, 229 (127 intervention and 102 control) had baseline ESAS SDS scores above the median (high baseline symptom group) and 232 (101 intervention and 131 control) had baseline ESAS SDS scores at or below the median (low baseline symptom group) (Figure¬†<xref rid="cam44565-fig-0001" ref-type="fig">1</xref>).</p>
              <fig position="float" fig-type="FIGURE" id="cam44565-fig-0001">
                <label>FIGURE 1</label>
                <caption>
                  <p>Study design</p>
                </caption>
                <graphic xlink:href="CAM4-11-1869-g002" position="anchor" id="jats-graphic-1"/>
              </fig>
              <p>The mean (SD) baseline ESAS SDS was 38.5 (11.1) in the high baseline symptom group and 12.7 (6.4) in the low baseline symptom group. The baseline characteristics of patients in the intervention and control arms, for those with high and low baseline symptoms, are shown in Table¬†<xref rid="cam44565-tbl-0001" ref-type="table">1</xref>. For those with high baseline symptoms, there was no significant difference in baseline demographic characteristics or outcome measures between the intervention and control arms. For those with low baseline symptoms, patients in the intervention arm were more likely than those in the control arm to have worse baseline ESAS SDS, FAMCARE‚ÄêP16, and CARES‚ÄêMIS scores (Table¬†<xref rid="cam44565-tbl-0001" ref-type="table">1</xref>).</p>
              <table-wrap position="float" id="cam44565-tbl-0001" content-type="TABLE">
                <label>TABLE 1</label>
                <caption>
                  <p>Baseline characteristics by symptom subgroup and study arm</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <thead valign="bottom">
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"/>
                      <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Low baseline symptoms</th>
                      <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">High baseline symptoms</th>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Baseline characteristic no. (%)</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Intervention <italic toggle="yes">n</italic>¬†=¬†101</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Control <italic toggle="yes">n</italic>¬†=¬†131</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">
                        <italic toggle="yes">p</italic>
                      </th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Intervention <italic toggle="yes">n</italic>¬†=¬†127</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Control <italic toggle="yes">n</italic>¬†=¬†102</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">
                        <italic toggle="yes">p</italic>
                      </th>
                    </tr>
                  </thead>
                  <tbody valign="top">
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Age, mean (¬± SD)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">61.6 (11.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">61.4 (12.1)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.84</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">61.0 (12.2)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">58.6 (10.2)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.11</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Female</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">50 (49.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">62 (47.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.74</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">42 (33.1)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">46 (45.1)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.06</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Married</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">72 (71.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">91 (69.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.76</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">84 (66.1)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">76 (74.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.17</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Living alone</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">18 (17.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">27 (20.6)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.59</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">25 (19.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">15 (14.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.32</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Employment status</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.21</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.20</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Retired</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">49 (48.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">64 (48.9)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">55 (43.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">37 (36.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Employed</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">22 (21.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">38 (29.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">23 (18.1)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">21 (20.6)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Unemployed</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">9 (8.9)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">14 (10.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">20 (15.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">10 (9.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Disability</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">21 (20.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">15 (11.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">29 (22.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">34 (33.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Education</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.52</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.12</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Below high school</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">7 (7.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">7 (5.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">11 (8.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">17 (16.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">High school</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">22 (22.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">37 (28.2)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">34 (27.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">20 (19.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">College/university/other</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">71 (71.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">87 (66.4)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">81 (64.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">64 (63.4)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Missing</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Tumor Site</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.06</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.12</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Breast</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">13 (12.9)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">20 (15.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">28 (22.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">11 (10.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Gastrointestinal</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">46 (45.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">39 (29.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">28 (22.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">26 (25.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Genitourinary</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">13 (12.9)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">33 (25.2)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">14 (11.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">18 (17.6)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Gynecological</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">12 (11.9)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">20 (15.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">19 (15.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">20 (19.6)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Lung</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">17 (16.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">19 (14.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">38 (29.9)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">27 (26.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Active systemic cancer treatment</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">72 (71.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">105 (80.2)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.12</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">102 (80.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">76 (74.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.29</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Radiation treatment within 14¬†days</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">5 (5.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">4 (3.1)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.46</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">11 (8.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">9 (8.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.97</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">CCI score &gt;0<xref rid="cam44565-note-0002" ref-type="table-fn"><sup>a</sup></xref>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">33 (32.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">47 (35.9)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.61</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">42 (33.1)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">24 (23.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.11</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">ECOG performance status<xref rid="cam44565-note-0003" ref-type="table-fn"><sup>b</sup></xref>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.88</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.71</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">0</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">39 (38.6)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">54 (41.2)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">22 (17.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">22 (21.6)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">58 (57.4)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">73 (55.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">91 (71.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">70 (68.6)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">4 (4.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">4 (3.1)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">14 (11.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">10 (9.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Baseline mean FACIT‚ÄêSp scores (¬± SD)<xref rid="cam44565-note-0004" ref-type="table-fn"><sup>c</sup></xref>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">112.5¬†¬±¬†16.7</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">113.8¬†¬±¬†14.2</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.78</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">91.4¬†¬±¬†18.0</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">92.6¬†¬±¬†17.3</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.89</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Baseline mean QUAL‚ÄêE scores (¬± SD)<xref rid="cam44565-note-0005" ref-type="table-fn"><sup>d</sup></xref>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">77.4¬†¬±¬†10.8</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">79.0¬†¬±¬†10.5</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.21</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">68.8¬†¬±¬†10.0</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">68.6¬†¬±¬†10.0</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.99</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Baseline mean ESAS SDS scores (¬± SD)<xref rid="cam44565-note-0006" ref-type="table-fn"><sup>e</sup></xref>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">13.9¬†¬±¬†6.3</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">11.9¬†¬±¬†6.3</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.01</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">38.7¬†¬±¬†11.2</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">38.2¬†¬±¬†11.1</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.71</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Baseline mean FAMCARE‚ÄêP16 scores (¬± SD)<xref rid="cam44565-note-0007" ref-type="table-fn"><sup>f</sup></xref>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">66.0¬†¬±¬†9.9</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">70.0¬†¬±¬†9.0</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.002</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">63.3¬†¬±¬†9.4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">65.0¬†¬±¬†9.9</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.10</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Baseline mean CARES‚ÄêMIS scores (¬± SD)<xref rid="cam44565-note-0008" ref-type="table-fn"><sup>g</sup></xref>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">4.0¬†¬±¬†5.3</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">2.6¬†¬±¬†3.7</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.04</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">5.2¬†¬±¬†5.8</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">5.7¬†¬±¬†6.7</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.8</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot id="cam44565-ntgp-0001">
                  <fn id="cam44565-note-0001">
                    <p>Abbreviations: CARES‚ÄêMIS, cancer rehabilitation evaluation system medical interaction subscale; CCI, charlson comorbidity index; ECOG, eastern cooperative oncology group; ESAS SDS, edmonton symptom assessment system symptom distress score; FACIT‚ÄêSp, functional assessment of chronic illness therapy‚Äîspiritual well‚Äêbeing scale; FAMCARE‚ÄêP16, FAMCARE patient satisfaction with care measure; QUAL‚ÄêE, quality of life at the end of life scale.</p>
                  </fn>
                  <fn id="cam44565-note-0002">
                    <label>
                      <sup>a</sup>
                    </label>
                    <p>The CCI is a measure of comorbidity for patients with cancer; higher scores indicate more severe comorbid conditions.</p>
                  </fn>
                  <fn id="cam44565-note-0003">
                    <label>
                      <sup>b</sup>
                    </label>
                    <p>An ECOG performance status score of 0¬†=¬†fully active at pre‚Äêdisease performance; 1¬†=¬†ambulatory but restricted in physically strenuous activity; 2¬†=¬†not fully ambulatory but lying or sitting &lt;50% of the day.</p>
                  </fn>
                  <fn id="cam44565-note-0004">
                    <label>
                      <sup>c</sup>
                    </label>
                    <p>The FACIT‚ÄêSp scale ranges from 0 to 156; higher numbers indicate better quality of life.</p>
                  </fn>
                  <fn id="cam44565-note-0005">
                    <label>
                      <sup>d</sup>
                    </label>
                    <p>The QUAL‚ÄêE scale ranges from 21 to 105; higher numbers indicate better quality of life.</p>
                  </fn>
                  <fn id="cam44565-note-0006">
                    <label>
                      <sup>e</sup>
                    </label>
                    <p>The FAMCARE‚ÄêP16 scale ranges from 16 to 80; higher numbers indicate better patient satisfaction with care.</p>
                  </fn>
                  <fn id="cam44565-note-0007">
                    <label>
                      <sup>f</sup>
                    </label>
                    <p>The ESAS SDS scale ranges from 0 to 90; higher numbers indicate worse symptom burden.</p>
                  </fn>
                  <fn id="cam44565-note-0008">
                    <label>
                      <sup>g</sup>
                    </label>
                    <p>The CARES‚ÄêMIS subscale ranges from 0 to 44; higher numbers indicate greater problems with medical interactions.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>As shown in Table¬†<xref rid="cam44565-tbl-0002" ref-type="table">2</xref> and Figure¬†<xref rid="cam44565-fig-0002" ref-type="fig">2</xref>, among participants who received early palliative care, those in the high baseline symptom group had a significant improvement in FACIT‚ÄêSp scores at 4¬†months compared to controls (adjusted mean difference in change scores +8.7; 95% CI 2.8‚Äì14.5, <italic toggle="yes">p</italic>¬†=¬†0.01). There was no improvement in the low baseline symptom subgroup (+2.9; 95% CI ‚àí3.7 to 9.5, <italic toggle="yes">p</italic>¬†=¬†0.36); the interaction term was not significant (<italic toggle="yes">p</italic> for interaction, 0.16). Similar results were demonstrated for the QUAL‚ÄêE score, which was significantly improved in those in the high baseline symptom group who received early palliative care compared to those who received standard care (adjusted mean difference [AMD] in change scores +4.2; 95% CI 0.9‚Äì7.5, <italic toggle="yes">p</italic>¬†=¬†0.02). There was no significant improvement in QUAL‚ÄêE scores among those in the low baseline symptom group who received the intervention compared to those who received standard care (+0.6; 95% CI ‚àí2.6 to 3.7, <italic toggle="yes">p</italic>¬†=¬†0.59). For ESAS SDS scores, there was no significant difference between early palliative care and standard care arms in those with high baseline symptoms (AMD ‚àí5.6, 95% CI ‚àí12.7 to 1.4, <italic toggle="yes">p</italic>¬†=¬†0.11), nor in those with low baseline symptoms (‚àí0.2, 95% CI ‚àí5.3 to 4.9, <italic toggle="yes">p</italic>¬†=¬†0.92).</p>
              <table-wrap position="float" id="cam44565-tbl-0002" content-type="TABLE">
                <label>TABLE 2</label>
                <caption>
                  <p>Estimated adjusted mean changes in quality‚Äêof‚Äêlife scores (FACIT‚ÄêSp, QUAL‚ÄêE) and symptom burden (ESAS SDS) in high and low baseline symptom subgroups at 4¬†months</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col align="left" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <thead valign="bottom">
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"/>
                      <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Intervention</th>
                      <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Control</th>
                      <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1"/>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"/>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">
                        <italic toggle="yes">n</italic>
                      </th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Observed change from baseline Mean (SD)</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">
                        <italic toggle="yes">n</italic>
                      </th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Observed change from baseline Mean (SD)</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Adjusted difference in change scores between study arms (95% CI)</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">
                        <italic toggle="yes">p</italic>
                      </th>
                    </tr>
                  </thead>
                  <tbody valign="top">
                    <tr>
                      <td colspan="6" align="left" valign="top" rowspan="1">FACIT‚ÄêSp total score</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.16<xref rid="cam44565-note-0011" ref-type="table-fn"><sup>a</sup></xref>
</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">High baseline symptoms</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">66</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5.1 (13.3)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">56</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">‚àí3.0 (15.2)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">8.7 (2.8 to 14.5)<xref rid="cam44565-note-0012" ref-type="table-fn"><sup>b</sup></xref>
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.01</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low baseline symptoms</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">56</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">‚àí0.7 (17.3)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">93</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">‚àí4.5 (13.6)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.9 (‚àí3.7 to 9.5)<xref rid="cam44565-note-0012" ref-type="table-fn"><sup>b</sup></xref>
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.36</td>
                    </tr>
                    <tr>
                      <td colspan="6" align="left" valign="top" rowspan="1">QUAL‚ÄêE total score</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.09<xref rid="cam44565-note-0011" ref-type="table-fn"><sup>a</sup></xref>
</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">High baseline symptoms</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">65</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">4.5 (7.7)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">57</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.3 (6.8)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">4.2 (0.9 to 7.5)<xref rid="cam44565-note-0013" ref-type="table-fn"><sup>c</sup></xref>
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.02</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low baseline symptoms</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">56</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.3 (8.8)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">91</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">‚àí1.0 (8.1)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.6 (‚àí2.6 to 3.7)<xref rid="cam44565-note-0013" ref-type="table-fn"><sup>c</sup></xref>
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.59</td>
                    </tr>
                    <tr>
                      <td colspan="6" align="left" valign="top" rowspan="1">ESAS SDS score</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.10<xref rid="cam44565-note-0011" ref-type="table-fn"><sup>a</sup></xref>
</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">High baseline symptoms</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">69</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">‚àí7.9 (14.2)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">58</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">‚àí3.4 (14.4)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">‚àí5.6 (‚àí12.7 to 1.4)<xref rid="cam44565-note-0014" ref-type="table-fn"><sup>d</sup></xref>
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.11</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low baseline symptoms</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">62</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">6.0 (14.7)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">97</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">7.2 (12.0)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">‚àí0.2 (‚àí5.3 to 4.9)<xref rid="cam44565-note-0014" ref-type="table-fn"><sup>d</sup></xref>
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.92</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot id="cam44565-ntgp-0002">
                  <fn id="cam44565-note-0009">
                    <p>Abbreviations: ESAS SDS, edmonton symptom assessment system symptom distress score; FACIT‚ÄêSp, functional assessment of chronic illness therapy‚Äîspiritual well‚Äêbeing scale; QUAL‚ÄêE, quality of life at the end of life scale.</p>
                  </fn>
                  <fn id="cam44565-note-0010">
                    <p>Sensitivity analyses using MCMC multiple imputation: for FACIT‚ÄêSp, the adjusted difference in change scores was 6.5 (95% CI, 0.6‚Äì12.3; <italic toggle="yes">p</italic>¬†=¬†0.03) for high baseline symptom group vs. 3.5 (‚àí1.39 to 8.36; <italic toggle="yes">p</italic>¬†=¬†0.16) for low baseline symptom group, <italic toggle="yes">p</italic> for interaction¬†=¬†0.38; for QUAL‚ÄêE, 3.6 (0.5‚Äì6.7; <italic toggle="yes">p</italic>¬†=¬†0.02) for high baseline symptom group vs. 1.9 (‚àí0.5 to 4.3; <italic toggle="yes">p</italic>¬†=¬†0.12) for low baseline symptom group, <italic toggle="yes">p</italic> for interaction¬†=¬†0.37; and for ESAS SDS, ‚àí4.2 (‚àí9.7 to 1.4; <italic toggle="yes">p</italic>¬†=¬†0.14) for high baseline symptom group vs. ‚Äê0.9 (‚àí5.3 to 3.5; <italic toggle="yes">p</italic>¬†=¬†0.70) for low baseline symptom group, <italic toggle="yes">p</italic> for interaction¬†=¬†0.33.</p>
                  </fn>
                  <fn id="cam44565-note-0011">
                    <label>
                      <sup>a</sup>
                    </label>
                    <p><italic toggle="yes">p</italic>‚Äêvalue for interaction between high/low baseline symptom subgroups and study arm.</p>
                  </fn>
                  <fn id="cam44565-note-0012">
                    <label>
                      <sup>b</sup>
                    </label>
                    <p>Adjusted for age, tumor site, baseline ECOG score, receiving systemic cancer treatment, and baseline FACIT‚ÄêSp total score.</p>
                  </fn>
                  <fn id="cam44565-note-0013">
                    <label>
                      <sup>c</sup>
                    </label>
                    <p>Adjusted for age, tumor site, baseline ECOG score, receiving systemic cancer treatment, and baseline QUAL‚ÄêE total score.</p>
                  </fn>
                  <fn id="cam44565-note-0014">
                    <label>
                      <sup>d</sup>
                    </label>
                    <p>Adjusted for age, tumor site, baseline ECOG score, receiving systemic cancer treatment, and baseline ESAS SDS score.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <fig position="float" fig-type="FIGURE" id="cam44565-fig-0002">
                <label>FIGURE 2</label>
                <caption>
                  <p>Estimated adjusted mean change in FACIT‚ÄêSp, QUAL‚ÄêE, ESAS SDS, FAMCARE‚ÄêP16, and CARES‚ÄêMIS total scores in high and low baseline symptom subgroups at 4¬†months</p>
                </caption>
                <graphic xlink:href="CAM4-11-1869-g001" position="anchor" id="jats-graphic-3"/>
              </fig>
              <p>Results for the FAMCARE‚ÄêP16 and CARES‚ÄêMIS outcomes are shown in Table¬†<xref rid="cam44565-tbl-0003" ref-type="table">3</xref> and Figure¬†<xref rid="cam44565-fig-0002" ref-type="fig">2</xref>. Among those assigned to early palliative care, those in the high baseline symptom group had a significant improvement in FAMCARE‚ÄêP16 at 4¬†months compared to controls (AMD +6.9; 95% CI 3.8‚Äì9.9, <italic toggle="yes">p</italic>¬†=¬†0.001), whereas there was no significant improvement in the low baseline symptom group (+3.4; 95% CI ‚àí0.5 to 7.4, <italic toggle="yes">p</italic>¬†=¬†0.08). Similarly, the high baseline symptom group reported improved clinician‚Äêpatient interactions (AMD for CARES‚ÄêMIS ‚àí1.7; 95% CI ‚àí3.4 to ‚àí0.1, <italic toggle="yes">p</italic>¬†=¬†0.04), whereas there was no improvement in the low baseline symptom group (+0.2; 95% CI ‚àí1.3 to 1.7, <italic toggle="yes">p</italic>¬†=¬†0.77). The <italic toggle="yes">p</italic> for interaction was 0.06 for CARES‚ÄêMIS and 0.13 for FAMCARE‚ÄêP16.</p>
              <table-wrap position="float" id="cam44565-tbl-0003" content-type="TABLE">
                <label>TABLE 3</label>
                <caption>
                  <p>Estimated adjusted mean change in FAMCARE‚ÄêP16 and CARES‚ÄêMIS total scores in high and low baseline symptom subgroups at 4¬†months</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <thead valign="bottom">
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" rowspan="3" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1"/>
                      <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Intervention</th>
                      <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Control</th>
                      <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1"/>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">
                        <italic toggle="yes">n</italic>
                      </th>
                      <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Observed change from baseline</th>
                      <th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">
                        <italic toggle="yes">n</italic>
                      </th>
                      <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Observed change from baseline</th>
                      <th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">Adjusted difference in change scores between study arms (95% CI)</th>
                      <th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1">
                        <italic toggle="yes">p</italic>
                      </th>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Mean (SD)</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Mean (SD)</th>
                    </tr>
                  </thead>
                  <tbody valign="top">
                    <tr>
                      <td colspan="6" align="left" valign="top" rowspan="1">FAMCARE‚ÄêP16 total score</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.13<xref rid="cam44565-note-0017" ref-type="table-fn"><sup>a</sup></xref>
<sup>,</sup>
<xref rid="cam44565-note-0019" ref-type="table-fn"><sup>c</sup></xref>
</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">High baseline symptoms</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">64</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">4.3 (8.2)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">57</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">‚àí3.3 (8.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">6.9 (3.8 to 9.9)<xref rid="cam44565-note-0018" ref-type="table-fn"><sup>b</sup></xref>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.001</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low baseline symptoms</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">57</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">3.1 (9.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">96</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">‚àí1.9 (8.4)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">3.4 (‚àí0.5 to 7.4)<xref rid="cam44565-note-0018" ref-type="table-fn"><sup>b</sup></xref>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.08</td>
                    </tr>
                    <tr>
                      <td colspan="6" align="left" valign="top" rowspan="1">CARES‚ÄêMIS total score</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.06<xref rid="cam44565-note-0017" ref-type="table-fn"><sup>a</sup></xref>
</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">High baseline symptoms</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">64</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">‚àí0.8 (4.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">58</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1.0 (4.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">‚àí1.7 (‚àí3.4 to ‚àí0.1)<xref rid="cam44565-note-0020" ref-type="table-fn"><sup>d</sup></xref>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.04</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low baseline symptoms</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">59</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.1 (4.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">96</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.4 (3.1)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.2 (‚àí1.3 to 1.7)<xref rid="cam44565-note-0021" ref-type="table-fn"><sup>e</sup></xref>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0.77</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot id="cam44565-ntgp-0003">
                  <fn id="cam44565-note-0015">
                    <p>Abbreviations: CARES‚ÄêMIS, cancer rehabilitation evaluation system medical interaction subscale; FAMCARE patient satisfaction with care measure.</p>
                  </fn>
                  <fn id="cam44565-note-0016">
                    <p>Sensitivity analyses using MCMC multiple imputation: for FAMCARE‚ÄêP16, the adjusted difference in change scores was 5.9 (2.5‚Äì9.2; <italic toggle="yes">p</italic>¬†&lt;¬†0.001) for high baseline symptom group vs. 4.3 (1.5‚Äì7.2; <italic toggle="yes">p</italic>¬†=¬†0.004) for low baseline symptom group, <italic toggle="yes">p</italic> for interaction¬†=¬†0.34; for CARES‚ÄêMIS, ‚àí1.0 (‚àí2.6 to 0.7; <italic toggle="yes">p</italic>¬†=¬†0.25) for high baseline symptom group vs. ‚Äê0.1 (‚àí1.3 to 1.1; <italic toggle="yes">p</italic>¬†=¬†0.85) for low baseline symptom group, <italic toggle="yes">p</italic> for interaction¬†=¬†0.27.</p>
                  </fn>
                  <fn id="cam44565-note-0017">
                    <label>
                      <sup>a</sup>
                    </label>
                    <p><italic toggle="yes">p</italic>‚Äêvalue for interaction between high/low baseline symptom subgroups and study arm.</p>
                  </fn>
                  <fn id="cam44565-note-0018">
                    <label>
                      <sup>b</sup>
                    </label>
                    <p>Adjusted for age, tumor site, baseline ECOG score, receiving systemic cancer treatment, and baseline FAMCARE‚ÄêP16 total score.</p>
                  </fn>
                  <fn id="cam44565-note-0019">
                    <label>
                      <sup>c</sup>
                    </label>
                    <p>Adjusted for baseline FAMCARE‚ÄêP16 score to achieve model convergence.</p>
                  </fn>
                  <fn id="cam44565-note-0020">
                    <label>
                      <sup>d</sup>
                    </label>
                    <p>Adjusted for age, baseline ECOG score, receiving systemic cancer treatment, and baseline CARES‚ÄêMIS total score to achieve model convergence.</p>
                  </fn>
                  <fn id="cam44565-note-0021">
                    <label>
                      <sup>e</sup>
                    </label>
                    <p>Adjusted for age, tumor site, receiving systemic cancer treatment, ECOG scores, and baseline CARES‚ÄêMIS total score.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>In sensitivity analyses using MCMC imputation, there were significant differences between intervention and control groups for those with high, but not low, baseline symptoms in the primary outcome of FACIT‚ÄêSp as well as QUAL‚ÄêE, and nonsignificant results for ESAS SDS regardless of baseline symptom severity. For satisfaction with care and clinician‚Äêpatient interactions, those who received early palliative care had improved FAMCARE‚ÄêP16 scores within both the high and low symptom groups, whereas CARES‚ÄêMIS scores did not improve significantly for those in either symptom group.</p>
            </sec>
            <sec sec-type="discussion" id="cam44565-sec-0010">
              <label>4</label>
              <title>DISCUSSION</title>
              <p>The present subgroup analysis extends the findings of a cluster‚Äêrandomized controlled trial in patients with advanced cancer<xref rid="cam44565-bib-0003" ref-type="bibr"><sup>3</sup></xref> by demonstrating that early palliative improved quality of life, satisfaction with care, and clinician‚Äêpatient interactions at 4¬†months only in those with high baseline symptoms. For symptom control, which showed a marginal benefit from early palliative care in the original trial, there was no difference between the intervention and control arms in either the high or low baseline symptom group. In sensitivity analyses, the results were consistent for quality of life and symptom control, whereas for satisfaction with care those who received early palliative care benefitted regardless of symptom group; for clinician‚Äêpatient interactions, no benefit was demonstrated in either symptom group.</p>
              <p>The differential improvement from early palliative care in two quality of life measures among those with high, but not low, baseline symptoms is particularly striking given the lack of similar findings for symptom control. There are several possible reasons for these findings. Although the physical domain is important for quality of life, high baseline symptom burden may be a marker of greater palliative care needs across a range of other quality‚Äêof‚Äêlife domains. Specialized palliative care not only addresses symptoms,<xref rid="cam44565-bib-0020" ref-type="bibr"><sup>20</sup></xref> but also strengthens coping, provides holistic support for patients and their caregivers; provides guidance in decision‚Äêmaking; and assists patients in preparing for the future.<xref rid="cam44565-bib-0024" ref-type="bibr"><sup>24</sup></xref>, <xref rid="cam44565-bib-0025" ref-type="bibr"><sup>25</sup></xref>, <xref rid="cam44565-bib-0026" ref-type="bibr"><sup>26</sup></xref>, <xref rid="cam44565-bib-0027" ref-type="bibr"><sup>27</sup></xref> These interventions may lead to improvements in non‚Äêphysical domains of quality of life, such as social and spiritual wellbeing, life completion, end‚Äêof‚Äêlife preparation, and relationships with healthcare providers. The need for interventions to address these domains tends to increase with disease severity,<xref rid="cam44565-bib-0027" ref-type="bibr"><sup>27</sup></xref> as does symptom burden.<xref rid="cam44565-bib-0002" ref-type="bibr"><sup>2</sup></xref>, <xref rid="cam44565-bib-0028" ref-type="bibr"><sup>28</sup></xref> Thus symptoms may provide a marker for patients who require more care in all quality‚Äêof‚Äêlife domains.</p>
              <p>There are also several potential explanations for the lack of differential improvement in symptom burden. Although symptom control is a core domain of early palliative care,<xref rid="cam44565-bib-0015" ref-type="bibr"><sup>15</sup></xref>, <xref rid="cam44565-bib-0024" ref-type="bibr"><sup>24</sup></xref>, <xref rid="cam44565-bib-0025" ref-type="bibr"><sup>25</sup></xref> symptoms were mild in the total study sample at baseline. This ceiling effect, combined with reduced sample size and power for the subgroup analysis, may have made detection of symptom improvement difficult. Of note, in the high symptom group, there was a nonsignificant trend toward greater improvement of symptoms in the early palliative care arm than in controls, whereas, in the low symptom group, symptom control tended to worsen in both trial arms. Regression to the mean may have played a role in the trends for both high and low symptom groups, though the tendency for difference between arms in the high symptom group is noteworthy.<xref rid="cam44565-bib-0029" ref-type="bibr"><sup>29</sup></xref> Prior studies have shown that specialized palliative care improves symptom control,<xref rid="cam44565-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="cam44565-bib-0010" ref-type="bibr"><sup>10</sup></xref> which is addressed in up to 75% of early palliative care visits.<xref rid="cam44565-bib-0024" ref-type="bibr"><sup>24</sup></xref>
</p>
              <p>The more robust findings for patient satisfaction with care compared to clinician‚Äêpatient interactions in the current study were also demonstrated in the analysis for the original trial,<xref rid="cam44565-bib-0003" ref-type="bibr"><sup>3</sup></xref> despite the fact that items for the FAMCARE‚ÄêP16 and CARES‚ÄêMIS measures are similar. Indeed, for satisfaction with care, there was a tendency for improvement associated with early palliative care in both the high and low symptom groups, although the high symptom group improved to a greater extent. For clinician‚Äêpatient interactions, there was a much smaller effect only for those in the high symptom group, which was nonsignificant in the sensitivity analysis. These differences in results between similar measures may relate to the phrasing of items: FAMCARE‚ÄêP16 items emphasize the healthcare provider and are phrased positively (e.g. ‚ÄúDoctor's attention to your description of symptoms‚Äù; ‚ÄúThe availability of doctors to answer your questions‚Äù), whereas CARES‚ÄêMIS items are phrased negatively and emphasize the patient (e.g. ‚ÄúI have difficulty telling my doctor about new symptoms‚Äù; ‚ÄúI have difficulty asking doctors questions‚Äù). Perhaps due to this wording, CARES‚ÄêMIS results were highly skewed, without much room for improvement. The FAMCARE‚ÄêP16 also includes several items related to symptom control, including satisfaction with pain relief, information provided on how to treat pain, speed of symptom control, and physicians' thoroughness and attention to patient's description of symptoms,<xref rid="cam44565-bib-0021" ref-type="bibr"><sup>21</sup></xref>, <xref rid="cam44565-bib-0022" ref-type="bibr"><sup>22</sup></xref> compared to the CARES‚ÄêMIS, which contains only one item specifically on symptom control.<xref rid="cam44565-bib-0023" ref-type="bibr"><sup>23</sup></xref> Those with a higher symptom burden may improve most for these symptom‚Äêrelated items.</p>
              <p>Interpretation of our study findings may be considered in the context of the minimal clinically important difference (MCID) for health‚Äêrelated quality of life measures. Although no specific MCID has been established for any of the measures in the present study, some may be extrapolated from other quality of life measures. In that regard, a 5‚Äì10% change in quality‚Äêof‚Äêlife scores is generally considered to be significant.<xref rid="cam44565-bib-0030" ref-type="bibr"><sup>30</sup></xref>, <xref rid="cam44565-bib-0031" ref-type="bibr"><sup>31</sup></xref>, <xref rid="cam44565-bib-0032" ref-type="bibr"><sup>32</sup></xref>, <xref rid="cam44565-bib-0033" ref-type="bibr"><sup>33</sup></xref>, <xref rid="cam44565-bib-0034" ref-type="bibr"><sup>34</sup></xref> A change in FACIT‚ÄêSp total score of 8.25 points (5.2%) from baseline was used in the original cluster‚Äêrandomized controlled trial to calculate the sample size, based on evidence supporting this as the MCID.<xref rid="cam44565-bib-0030" ref-type="bibr"><sup>30</sup></xref>, <xref rid="cam44565-bib-0031" ref-type="bibr"><sup>31</sup></xref>, <xref rid="cam44565-bib-0032" ref-type="bibr"><sup>32</sup></xref>, <xref rid="cam44565-bib-0033" ref-type="bibr"><sup>33</sup></xref>, <xref rid="cam44565-bib-0034" ref-type="bibr"><sup>34</sup></xref> In our study, the change in FACIT‚ÄêSp scores observed among those with high baseline symptoms was found to be above the MCID, with a mean change of 8.7 points from baseline, supporting the clinical significance of our findings. For our secondary quality‚Äêof‚Äêlife outcome, the mean change in QUAL‚ÄêE score was 4.2 points (4%) from baseline. While this is less than the 5% change estimated as an MCID for quality‚Äêof‚Äêlife measures, a validated MCID for QUAL‚ÄêE has yet to be determined and MCID values may be subject to change based on study population and context.<xref rid="cam44565-bib-0035" ref-type="bibr"><sup>35</sup></xref> In general, these results are consistent with those of reviews and meta‚Äêanalyses demonstrating that effect sizes for the impact of palliative care on quality of life are significant but small.<xref rid="cam44565-bib-0004" ref-type="bibr"><sup>4</sup></xref>, <xref rid="cam44565-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="cam44565-bib-0009" ref-type="bibr"><sup>9</sup></xref> No MCID values are available for satisfaction with care or clinician‚Äêpatient interactions.</p>
              <p>Various consensus‚Äêbased criteria have been proposed to prioritize referrals by primary and secondary providers to specialized palliative care. These criteria tend to fall into the general categories of physical symptoms, cancer trajectory, prognosis, performance status, psychosocial distress, and end‚Äêof‚Äêlife care planning.<xref rid="cam44565-bib-0013" ref-type="bibr"><sup>13</sup></xref>, <xref rid="cam44565-bib-0036" ref-type="bibr"><sup>36</sup></xref> However, there is a need for evidence to establish clearly defined criteria to identify the patients most likely to benefit from early palliative care intervention. Such criteria are most likely to be utilized if they are based on symptoms or functions that are already routinely assessed or can be assessed relatively easily in clinical practice. Symptom screening is already routinely conducted in many oncology settings<xref rid="cam44565-bib-0010" ref-type="bibr"><sup>10</sup></xref>, <xref rid="cam44565-bib-0012" ref-type="bibr"><sup>12</sup></xref>, <xref rid="cam44565-bib-0037" ref-type="bibr"><sup>37</sup></xref> and could be linked to triaged early palliative care rather than relying on oncologist referral.</p>
              <p>This study has limitations. While it stems from a sound clinical rationale, the subgroup analysis was unplanned, and the study was not powered for this analysis. Generalizability is limited as participants were mainly of European ethnicity, English‚Äêspeaking, well‚Äêeducated, and receiving treatment in a large, urban, comprehensive cancer center. The confidence intervals reported in this study are relatively wide; this is likely due to splitting the sample into two separately analyzed groups, which reduced power. Selection bias due to randomization of clusters before consent of individuals is a limitation of cluster‚Äêrandomized trials, including this study.<xref rid="cam44565-bib-0003" ref-type="bibr"><sup>3</sup></xref>, <xref rid="cam44565-bib-0038" ref-type="bibr"><sup>38</sup></xref>, <xref rid="cam44565-bib-0039" ref-type="bibr"><sup>39</sup></xref> Blinding of those in the intervention group was impossible, although neither trial arm was aware of the existence of the other.<xref rid="cam44565-bib-0003" ref-type="bibr"><sup>3</sup></xref> As well, the attrition rate in the current study was higher in the high baseline symptom group compared to the low baseline symptom group. Although this is expected as those with a higher symptom burden might be more likely to drop out or die, it may affect the validity of our findings. Nevertheless, our sensitivity analyses performed with this limitation in mind were broadly consistent with the main findings.</p>
              <p>Overall, our study findings suggest that symptom severity may be an appropriate screening mechanism to identify patients who would most benefit from early palliative care and to trigger early palliative care referrals. Further trials with longer follow‚Äêup are needed to assess the feasibility and effectiveness of a triaged model of early palliative care.</p>
            </sec>
            <sec sec-type="COI-statement" id="cam44565-sec-0012">
              <title>CONFLICT OF INTEREST</title>
              <p>We declare that we have no competing conflicts of interest.</p>
            </sec>
            <sec id="cam44565-sec-0013">
              <title>AUTHOR CONTRIBUTIONS</title>
              <p>Rebecca Rodin: Conceptualization and design, analysis and interpretation of data, writing and critical revision of the report. Nadia Swami: Acquisition and interpretation of data, critical revision of the report, administrative support. Ashley Pope: Interpretation of data, critical revision of the report, administrative support. David Hui: Interpretation of data and critical revision of the report. Breffni Hannon: Interpretation of data and critical revision of the report. Lisa Le: Conceptualization and design, formal analysis and interpretation of data, writing and critical revision of the report. Camilla Zimmermann: Conceptualization and design, analysis and interpretation of data, writing and critical revision of the report. All authors have provided final approval of the version to be published and have agreed to be accountable for all aspects of the work.</p>
            </sec>
            <sec id="cam44565-sec-0014">
              <title>ETHICS STATEMENT</title>
              <p>This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the University Health Network Research Ethics Board (#06‚Äê0525‚ÄêCE).</p>
            </sec>
            <sec id="cam44565-sec-0015">
              <title>Funding information</title>
              <p>This study was funded by the Canadian Cancer Society (CZ; grant number 700862) and the Canadian Institutes of Health Research (CZ; grant number 152996).</p>
            </sec>
            <sec id="cam44565-sec-0016">
              <title>CLINICAL TRIAL REGISTRATION</title>
              <p><ext-link xlink:href="http://clinicaltrials.gov" ext-link-type="uri">ClinicalTrials.gov</ext-link> Identifier: NCT01248624.</p>
            </sec>
          </body>
          <back>
            <ack id="cam44565-sec-0011">
              <title>ACKNOWLEDGMENTS</title>
              <p>Camilla Zimmermann is supported by the Harold and Shirley Lederman Chair in Psychosocial Oncology and Palliative Care, a joint Chair among the University of Toronto, Princess Margaret Cancer Centre/University Health Network and the Princess Margaret Cancer Foundation.</p>
            </ack>
            <sec sec-type="data-availability" id="cam44565-sec-0018">
              <title>DATA AVAILABILITY STATEMENT</title>
              <p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p>
            </sec>
            <ref-list content-type="cited-references" id="cam44565-bibl-0001">
              <title>REFERENCES</title>
              <ref id="cam44565-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0001"><string-name><surname>Teunissen</surname><given-names>SC</given-names></string-name>, <string-name><surname>Wesker</surname><given-names>W</given-names></string-name>, <string-name><surname>Kruitwagen</surname><given-names>C</given-names></string-name>, <string-name><surname>de Haes</surname><given-names>HC</given-names></string-name>, <string-name><surname>Voest</surname><given-names>EE</given-names></string-name>, <string-name><surname>de Graeff</surname><given-names>A</given-names></string-name>. <article-title>Symptom prevalence in patients with incurable cancer: a systematic review</article-title>. <source>J Pain Symptom Manag</source>. <year>2007</year>;<volume>34</volume>(<issue>1</issue>):<fpage>94</fpage>‚Äê<lpage>104</lpage>.</mixed-citation>
              </ref>
              <ref id="cam44565-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0002"><string-name><surname>Barbera</surname><given-names>L</given-names></string-name>, <string-name><surname>Seow</surname><given-names>H</given-names></string-name>, <string-name><surname>Howell</surname><given-names>D</given-names></string-name>, et al. <article-title>Symptom burden and performance status in a population‚Äêbased cohort of ambulatory cancer patients</article-title>. <source>Cancer</source>. <year>2010</year>;<volume>116</volume>(<issue>24</issue>):<fpage>5767</fpage>‚Äê<lpage>5776</lpage>.<pub-id pub-id-type="pmid">21136579</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0003"><string-name><surname>Zimmermann</surname><given-names>C</given-names></string-name>, <string-name><surname>Swami</surname><given-names>N</given-names></string-name>, <string-name><surname>Krzyzanowska</surname><given-names>M</given-names></string-name>, et al. <article-title>Early palliative care for patients with advanced cancer: a cluster‚Äêrandomised controlled trial</article-title>. <source>Lancet</source>. <year>2014</year>;<volume>383</volume>(<issue>9930</issue>):<fpage>1721</fpage>‚Äê<lpage>1730</lpage>.<pub-id pub-id-type="pmid">24559581</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0004"><string-name><surname>Gaertner</surname><given-names>J</given-names></string-name>, <string-name><surname>Siemens</surname><given-names>W</given-names></string-name>, <string-name><surname>Meerpohl</surname><given-names>JJ</given-names></string-name>, et al. <article-title>Effect of specialist palliative c are services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta‚Äêanalysis</article-title>. <source>BMJ</source>. <year>2017</year>;<volume>357</volume>:<elocation-id>j2925</elocation-id>.<pub-id pub-id-type="pmid">28676557</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0005"><string-name><surname>Temel</surname><given-names>JS</given-names></string-name>, <string-name><surname>Greer</surname><given-names>JA</given-names></string-name>, <string-name><surname>Muzikansky</surname><given-names>A</given-names></string-name>, et al. <article-title>Early palliative care for patients with metastatic non‚Äêsmall‚Äêcell lung cancer</article-title>. <source>N Engl J Med</source>. <year>2010</year>;<volume>363</volume>(<issue>8</issue>):<fpage>733</fpage>‚Äê<lpage>742</lpage>.<pub-id pub-id-type="pmid">20818875</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0006"><string-name><surname>Kavalieratos</surname><given-names>D</given-names></string-name>, <string-name><surname>Corbelli</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D</given-names></string-name>, et al. <article-title>Association between palliative care and patient and caregiver outcomes: a systematic review and meta‚Äêanalysis</article-title>. <source>JAMA</source>. <year>2016</year>;<volume>316</volume>(<issue>20</issue>):<fpage>2104</fpage>‚Äê<lpage>2114</lpage>.<pub-id pub-id-type="pmid">27893131</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0007"><string-name><surname>Lupu</surname><given-names>D</given-names></string-name>, <collab collab-type="authors">American Academy of Palliative Medicine Workforce Task Force</collab>
. <article-title>Estimate of current hospice and palliative medicine physician workforce shortage</article-title>. <source>J Pain Symptom Manag</source>. <year>2010</year>;<volume>40</volume>(<issue>6</issue>):<fpage>899</fpage>‚Äê<lpage>911</lpage>.</mixed-citation>
              </ref>
              <ref id="cam44565-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0008"><string-name><surname>Kamal</surname><given-names>AF</given-names></string-name>, <string-name><surname>Bull</surname><given-names>JH</given-names></string-name>, <string-name><surname>Swetz</surname><given-names>KM</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>SP</given-names></string-name>, <string-name><surname>Shanafelt</surname><given-names>TD</given-names></string-name>, <string-name><surname>Myers</surname><given-names>ER</given-names></string-name>. <article-title>Future of the palliative care workforce: preview to an impending crisis</article-title>. <source>Am J Med</source>. <year>2017</year>;<volume>130</volume>(<issue>2</issue>):<fpage>113</fpage>‚Äê<lpage>114</lpage>.<pub-id pub-id-type="pmid">27687068</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0009"><string-name><surname>Hui</surname><given-names>D</given-names></string-name>, <string-name><surname>Hannon</surname><given-names>BL</given-names></string-name>, <string-name><surname>Zimmermann</surname><given-names>C</given-names></string-name>, <string-name><surname>Bruera</surname><given-names>E</given-names></string-name>. <article-title>Improving patient and caregiver outcomes in oncology: team‚Äêbased, timely, and targeted palliative care</article-title>. <source>CA Cancer J Clin</source>. <year>2018</year>;<volume>68</volume>(<issue>5</issue>):<fpage>356</fpage>‚Äê<lpage>376</lpage>.<pub-id pub-id-type="pmid">30277572</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0010"><string-name><surname>Dudgeon</surname><given-names>D</given-names></string-name>, <string-name><surname>King</surname><given-names>S</given-names></string-name>, <string-name><surname>Howell</surname><given-names>S</given-names></string-name>, et al. <article-title>Cancer Care Ontario's experience with implementation of routine physical and psychological symptom distress screening</article-title>. <source>Psychooncology</source>. <year>2021</year>;<volume>21</volume>(<issue>4</issue>):<fpage>357</fpage>‚Äê<lpage>364</lpage>.</mixed-citation>
              </ref>
              <ref id="cam44565-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0011"><string-name><surname>Hui</surname><given-names>D</given-names></string-name>, <string-name><surname>Titus</surname><given-names>A</given-names></string-name>, <string-name><surname>Curtis</surname><given-names>T</given-names></string-name>, et al. <article-title>Implementation of the Edmonton symptom assessment system for symptom distress screening at a community cancer center: a pilot program</article-title>. <source>Oncologist</source>. <year>2017</year>;<volume>22</volume>(<issue>8</issue>):<fpage>995</fpage>‚Äê<lpage>1001</lpage>.<pub-id pub-id-type="pmid">28476945</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0012"><string-name><surname>Li</surname><given-names>M</given-names></string-name>, <string-name><surname>Macedo</surname><given-names>A</given-names></string-name>, <string-name><surname>Crawford</surname><given-names>S</given-names></string-name>, et al. <article-title>Easier said than done: keys to successful implementation of the distress assessment and response tool (DART) program</article-title>. <source>J Oncol Pract</source>. <year>2016</year>;<volume>12</volume>(<issue>5</issue>):<fpage>e513</fpage>‚Äê<lpage>e526</lpage>.<pub-id pub-id-type="pmid">27048610</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0013"><string-name><surname>Wentlandt</surname><given-names>K</given-names></string-name>, <string-name><surname>Krzyzanowska</surname><given-names>MK</given-names></string-name>, <string-name><surname>Swami</surname><given-names>N</given-names></string-name>, <string-name><surname>Rodin</surname><given-names>GM</given-names></string-name>, <string-name><surname>le</surname><given-names>LW</given-names></string-name>, <string-name><surname>Zimmermann</surname><given-names>C</given-names></string-name>. <article-title>Referral practices of oncologists to specialized palliative care</article-title>. <source>J Clin Oncol</source>. <year>2012</year>;<volume>30</volume>(<issue>35</issue>):<fpage>4380</fpage>‚Äê<lpage>4386</lpage>.<pub-id pub-id-type="pmid">23109708</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0014"><string-name><surname>Zimmermann</surname><given-names>C</given-names></string-name>, <string-name><surname>Swami</surname><given-names>N</given-names></string-name>, <string-name><surname>Krzyanowska</surname><given-names>M</given-names></string-name>, et al. <article-title>Perceptions of palliative care among patients with advanced cancer and their caregivers</article-title>. <source>CMAJ</source>. <year>2016</year>;<volume>188</volume>(<issue>10</issue>):<fpage>E217</fpage>‚Äê<lpage>E227</lpage>.<pub-id pub-id-type="pmid">27091801</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0015"><string-name><surname>Zimmermann</surname><given-names>C</given-names></string-name>, <string-name><surname>Ryan</surname><given-names>S</given-names></string-name>, <string-name><surname>Hannon</surname><given-names>B</given-names></string-name>, et al. <article-title>Team‚Äêbased outpatient early pallaitive care: a complex cancer intervention</article-title>. <source>BMJ Support Palliat Care</source>. <year>2019</year>;<volume>0</volume>:<fpage>1</fpage>‚Äê<lpage>10</lpage>.</mixed-citation>
              </ref>
              <ref id="cam44565-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0016"><string-name><surname>Webster</surname><given-names>K</given-names></string-name>, <string-name><surname>Cella</surname><given-names>D</given-names></string-name>, <string-name><surname>Yost</surname><given-names>K</given-names></string-name>. <article-title>The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation</article-title>. <source>Health Qual Life Outcomes</source>. <year>2003</year>;<volume>1</volume>:<fpage>79</fpage>.<pub-id pub-id-type="pmid">14678568</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0017"><string-name><surname>Peterman</surname><given-names>AH</given-names></string-name>, <string-name><surname>Fitchett</surname><given-names>G</given-names></string-name>, <string-name><surname>Brady</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Hernandez</surname><given-names>L</given-names></string-name>, <string-name><surname>Cella</surname><given-names>D</given-names></string-name>. <article-title>Measuring spiritual well‚Äêbeing in people with cancer: the functional assessment of chronic illness therapy‚ÄîSpiritual Well‚Äêbeing Scale (FACIT‚ÄêSp)</article-title>. <source>Ann Behav Med</source>. <year>2002</year>;<volume>24</volume>(<issue>1</issue>):<fpage>49</fpage>‚Äê<lpage>58</lpage>.<pub-id pub-id-type="pmid">12008794</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0018"><string-name><surname>Steinhauser</surname><given-names>KE</given-names></string-name>, <string-name><surname>Clipp</surname><given-names>EC</given-names></string-name>, <string-name><surname>Bosworth</surname><given-names>HB</given-names></string-name>, et al. <article-title>Measuring quality of life at the end of life: validation of the QUAL‚ÄêE</article-title>. <source>Palliat Support Care</source>. <year>2004</year>;<volume>2</volume>:<fpage>3</fpage>‚Äê<lpage>14</lpage>.<pub-id pub-id-type="pmid">16594230</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0019"><string-name><surname>Bruera</surname><given-names>E</given-names></string-name>, <string-name><surname>Kuehn</surname><given-names>N</given-names></string-name>, <string-name><surname>Miller</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Selmser</surname><given-names>P</given-names></string-name>, <string-name><surname>Macmillan</surname><given-names>K</given-names></string-name>. <article-title>The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients</article-title>. <source>J Palliat Care</source>. <year>1991</year>;<volume>7</volume>(<issue>2</issue>):<fpage>6</fpage>‚Äê<lpage>9</lpage>.<pub-id pub-id-type="pmid">1714502</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0020"><string-name><surname>Follwell</surname><given-names>M</given-names></string-name>, <string-name><surname>Burman</surname><given-names>D</given-names></string-name>, <string-name><surname>Le</surname><given-names>LW</given-names></string-name>, et al. <article-title>Phase II study of an outpatient palliative care intervention in patients with metastatic cancer</article-title>. <source>J Clin Oncol</source>. <year>2009</year>;<volume>27</volume>(<issue>2</issue>):<fpage>206</fpage>‚Äê<lpage>213</lpage>.<pub-id pub-id-type="pmid">19064979</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0021"><string-name><surname>Lo</surname><given-names>C</given-names></string-name>, <string-name><surname>Burman</surname><given-names>D</given-names></string-name>, <string-name><surname>Hales</surname><given-names>S</given-names></string-name>, <string-name><surname>Swami</surname><given-names>N</given-names></string-name>, <string-name><surname>Rodin</surname><given-names>G</given-names></string-name>, <string-name><surname>Zimmermann</surname><given-names>C</given-names></string-name>. <article-title>The FAMCARE‚Äêpatient scale: measuring satisfaction with care of outpatients with advanced cancer</article-title>. <source>Eur J Cancer</source>. <year>2009</year>;<volume>45</volume>(<issue>18</issue>):<fpage>3182</fpage>‚Äê<lpage>3188</lpage>.<pub-id pub-id-type="pmid">19786345</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0022"><string-name><surname>Lo</surname><given-names>C</given-names></string-name>, <string-name><surname>Burman</surname><given-names>D</given-names></string-name>, <string-name><surname>Rodin</surname><given-names>G</given-names></string-name>, <string-name><surname>Zimmermann</surname><given-names>C</given-names></string-name>. <article-title>Measuring patient satisfaction in oncology palliative care: psychometric properties of the FAMCARE‚Äêpatient scale</article-title>. <source>Qual Life Res</source>. <year>2009</year>;<volume>18</volume>(<issue>6</issue>):<fpage>747</fpage>‚Äê<lpage>752</lpage>.<pub-id pub-id-type="pmid">19513815</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0023"><string-name><surname>Schag</surname><given-names>CA</given-names></string-name>, <string-name><surname>Heinrich</surname><given-names>RL</given-names></string-name>, <string-name><surname>Aadland</surname><given-names>RL</given-names></string-name>, <string-name><surname>Ganz</surname><given-names>PA</given-names></string-name>. <article-title>Assessing problems of cancer patients: psychometric properties of the cancer inventory of problem situations</article-title>. <source>Health Psychol</source>. <year>1990</year>;<volume>9</volume>:<fpage>83</fpage>‚Äê<lpage>102</lpage>.<pub-id pub-id-type="pmid">2323331</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0024"><string-name><surname>Hoerger</surname><given-names>M</given-names></string-name>, <string-name><surname>Greer</surname><given-names>J</given-names></string-name>, <string-name><surname>Jackson</surname><given-names>V</given-names></string-name>, et al. <article-title>Defining the elements of early palliative care that are associated with patient‚Äêreported outcomes and the delivery of end‚Äêof‚Äêlife care</article-title>. <source>J Clin Oncol</source>. <year>2018</year>;<volume>36</volume>(<issue>10</issue>):<fpage>1096</fpage>‚Äê<lpage>1102</lpage>.<pub-id pub-id-type="pmid">29474102</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0025"><string-name><surname>Hannon</surname><given-names>B</given-names></string-name>, <string-name><surname>Swami</surname><given-names>N</given-names></string-name>, <string-name><surname>Rodin</surname><given-names>G</given-names></string-name>, <string-name><surname>Pope</surname><given-names>A</given-names></string-name>, <string-name><surname>Zimmermann</surname><given-names>C</given-names></string-name>. <article-title>Experiences of patients and caregivers with early palliative care: a qualitative study</article-title>. <source>Palliat Med</source>. <year>2017</year>;<volume>3</volume>(<issue>1</issue>):<fpage>72</fpage>‚Äê<lpage>78</lpage>.</mixed-citation>
              </ref>
              <ref id="cam44565-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0026"><string-name><surname>Hannon</surname><given-names>B</given-names></string-name>, <string-name><surname>Swami</surname><given-names>N</given-names></string-name>, <string-name><surname>Pope</surname><given-names>A</given-names></string-name>, et al. <article-title>Early palliative care and its role in oncology: a qualitative study</article-title>. <source>Oncologist</source>. <year>2016</year>;<volume>21</volume>(<issue>11</issue>):<fpage>1387</fpage>‚Äê<lpage>1395</lpage>.<pub-id pub-id-type="pmid">27449522</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0027"><string-name><surname>Yoong</surname><given-names>J</given-names></string-name>, <string-name><surname>Park</surname><given-names>E</given-names></string-name>, <string-name><surname>Greer</surname><given-names>J</given-names></string-name>, et al. <article-title>Early palliative care in advanced lung cancer: a qualitative study</article-title>. <source>JAMA Intern Med</source>. <year>2013</year>;<volume>173</volume>(<issue>4</issue>):<fpage>283</fpage>‚Äê<lpage>290</lpage>.<pub-id pub-id-type="pmid">23358690</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0028"><string-name><surname>Cheung</surname><given-names>WY</given-names></string-name>, <string-name><surname>Barmala</surname><given-names>N</given-names></string-name>, <string-name><surname>Zarinehbaf</surname><given-names>S</given-names></string-name>, <string-name><surname>Rodin</surname><given-names>G</given-names></string-name>, <string-name><surname>Le</surname><given-names>LW</given-names></string-name>, <string-name><surname>Zimmermann</surname><given-names>C</given-names></string-name>. <article-title>The asociation of physical and psychological symptom burden with time to death among palliative cancer outpatients</article-title>. <source>J Pain Symptom Manag</source>. <year>2009</year>;<volume>37</volume>(<issue>3</issue>):<fpage>297</fpage>‚Äê<lpage>304</lpage>.</mixed-citation>
              </ref>
              <ref id="cam44565-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0029"><string-name><surname>Carmona‚ÄêBayonas</surname><given-names>A</given-names></string-name>, <string-name><surname>Jimenez‚ÄêFonseca</surname><given-names>P</given-names></string-name>, <string-name><surname>Fern√°ndez‚ÄêSomoano</surname><given-names>A</given-names></string-name>, et al. <article-title>Top ten errors of statistical analysis in observational studies for cancer research</article-title>. <source>Clin Transl Oncol</source>. <year>2018</year>;<volume>20</volume>(<issue>8</issue>):<fpage>954</fpage>‚Äê<lpage>965</lpage>.<pub-id pub-id-type="pmid">29218627</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0030"><string-name><surname>Guyatt</surname><given-names>GH</given-names></string-name>, <string-name><surname>Osoba</surname><given-names>D</given-names></string-name>, <string-name><surname>Wu</surname><given-names>AW</given-names></string-name>, <string-name><surname>Wyrwich</surname><given-names>KW</given-names></string-name>, <string-name><surname>Norman</surname><given-names>GR</given-names></string-name>, <collab collab-type="authors">Clinical Significance Consensus Meeting Group</collab>
. <article-title>Methods to explain the clinical significance of health status measures</article-title>. <source>Mayo Clin Proc</source>. <year>2002</year>;<volume>77</volume>(<issue>4</issue>):<fpage>371</fpage>‚Äê<lpage>383</lpage>.<pub-id pub-id-type="pmid">11936935</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0031"><string-name><surname>Osoba</surname><given-names>D</given-names></string-name>. <article-title>A taxonomy of the uses of health‚Äêrelated quality‚Äêof‚Äêlife instruments in cancer care and the clinical meaningfulness of the results</article-title>. <source>Med Care</source>. <year>2002</year>;<volume>40</volume>(<issue>6 Suppl</issue>):<fpage>III31</fpage>‚Äê<lpage>III38</lpage>.<pub-id pub-id-type="pmid">12064756</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0032"><string-name><surname>Osoba</surname><given-names>D</given-names></string-name>. <article-title>What has been learned from measuring health‚Äêrelated quality of life in clinical oncology</article-title>. <source>Eur J Cancer</source>. <year>1999</year>;<volume>35</volume>(<issue>11</issue>):<fpage>1565</fpage>‚Äê<lpage>1570</lpage>.<pub-id pub-id-type="pmid">10673963</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0033"><string-name><surname>Ringash</surname><given-names>J</given-names></string-name>, <string-name><surname>O'Sullivan</surname><given-names>B</given-names></string-name>, <string-name><surname>Bezjak</surname><given-names>A</given-names></string-name>, <string-name><surname>Redelmeier</surname><given-names>DA</given-names></string-name>. <article-title>Interpreting clinically significant changes in patient‚Äêreported outcomes</article-title>. <source>Cancer</source>. <year>2007</year>;<volume>110</volume>(<issue>1</issue>):<fpage>196</fpage>‚Äê<lpage>202</lpage>.<pub-id pub-id-type="pmid">17546575</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0034"><string-name><surname>Osoba</surname><given-names>D</given-names></string-name>, <string-name><surname>Rodrigues</surname><given-names>G</given-names></string-name>, <string-name><surname>Myles</surname><given-names>J</given-names></string-name>, <string-name><surname>Zee</surname><given-names>B</given-names></string-name>, <string-name><surname>Pater</surname><given-names>J</given-names></string-name>. <article-title>Interpreting the significance of changes in health‚Äêrelated quality‚Äêof‚Äêlife scores</article-title>. <source>J Clin Oncol</source>. <year>1998</year>;<volume>16</volume>(<issue>1</issue>):<fpage>139</fpage>‚Äê<lpage>144</lpage>.<pub-id pub-id-type="pmid">9440735</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0035"><string-name><surname>Yost</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Eton</surname><given-names>DT</given-names></string-name>. <article-title>Combining distribution‚Äê and anchor‚Äêbased approaches to determine minimally important differences: the FACIT experience</article-title>. <source>Eval Health Prof</source>. <year>2005</year>;<volume>28</volume>(<issue>2</issue>):<fpage>2172</fpage>‚Äê<lpage>2191</lpage>.</mixed-citation>
              </ref>
              <ref id="cam44565-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0036"><string-name><surname>Hui</surname><given-names>D</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>L</given-names></string-name>, <string-name><surname>Tang</surname><given-names>M</given-names></string-name>, <string-name><surname>Park</surname><given-names>M</given-names></string-name>, <string-name><surname>Liu</surname><given-names>D</given-names></string-name>, <string-name><surname>Bruera</surname><given-names>E</given-names></string-name>. <article-title>Examination of referral criteria for outpatient palliative care among patients with advanced cancer</article-title>. <source>Support Care Cancer</source>. <year>2020</year>;<volume>28</volume>(<issue>1</issue>):<fpage>295</fpage>‚Äê<lpage>301</lpage>.<pub-id pub-id-type="pmid">31044305</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0037"><string-name><surname>Hui</surname><given-names>D</given-names></string-name>, <string-name><surname>Bruera</surname><given-names>E</given-names></string-name>. <article-title>The Edmonton symptom assessment system 25 years later: past, present, and future developments</article-title>. <source>J Pain Symptom Manag</source>. <year>2017</year>;<volume>53</volume>(<issue>3</issue>):<fpage>630</fpage>‚Äê<lpage>643</lpage>.</mixed-citation>
              </ref>
              <ref id="cam44565-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0038"><string-name><surname>Campbell</surname><given-names>MK</given-names></string-name>, <string-name><surname>Piaggo</surname><given-names>G</given-names></string-name>, <string-name><surname>Elbourne</surname><given-names>DR</given-names></string-name>, <string-name><surname>Altman</surname><given-names>DG</given-names></string-name>. <article-title>Consort 2010 statement: extension to randomised trials</article-title>. <source>BMJ</source>. <year>2012</year>;<volume>345</volume>:<elocation-id>e5661</elocation-id>.<pub-id pub-id-type="pmid">22951546</pub-id></mixed-citation>
              </ref>
              <ref id="cam44565-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="cam44565-cit-0039"><string-name><surname>Jordh√∏y</surname><given-names>MS</given-names></string-name>, <string-name><surname>Fayers</surname><given-names>P</given-names></string-name>, <string-name><surname>Loge</surname><given-names>JH</given-names></string-name>, <string-name><surname>Ahlner‚ÄêElmqvist</surname><given-names>M</given-names></string-name>, <string-name><surname>Kaasa</surname><given-names>S</given-names></string-name>. <article-title>Quality of life in palliative cancer care: results from a cluster randomized trial</article-title>. <source>J Clin Oncol</source>. <year>2001</year>;<volume>19</volume>(<issue>18</issue>):<fpage>3884</fpage>‚Äê<lpage>3894</lpage>.<pub-id pub-id-type="pmid">11559726</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
